Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants.
On 31 January 2022, the Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application.
A transition period applies to clinical trial submission under the Regulation.
Table of Contents
3. How to report a serious breach
4. Clarification on reporting requirements
5. Reporting serious breaches – Points to consider
6. Responsibilities of parties involved in the notification of a serious breach
7. General considerations for serious breaches
8. Possible actions taken by the EU/EEA Member States concerned (MSC)
Appendix I – Examples of serious breaches
Appendix II – Points to consider for sponsors in relation to the assessment of a breach
Appendix III a – Template form for reporting serious breaches
Appendix III b – Information to be submitted with a notification of a serious breach
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
10 – 11 April 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 18 April 2024InformaUnited States
-
17 – 19 April 2024SCDM (Society of Clinical Data Management)Poland
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Bevorstehende klinische Studien
-
Ruijin HospitalRekrutierungAntiphospholipid-Syndrom (APS)China
-
Cybrexa TherapeuticsNoch keine RekrutierungPlatinresistenter Eierstockkrebs | Refraktäres Ovarialkarzinom
-
Universidad Complutense de MadridOsteology FoundationRekrutierungZahnfehlstellung | Oberkiefer-MangelSpanien
-
Rhode Island HospitalBrown UniversityNoch keine Rekrutierung
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Institutes of Health (NIH)Noch keine Rekrutierung
-
Beijing Tiantan HospitalNoch keine RekrutierungIschämischer Schlaganfall | Kognitive Beeinträchtigung nach Schlaganfall
-
McGill University Health Centre/Research Institute...Noch keine RekrutierungGesunde Probanden | Typ-1-Diabetes (T1D)
-
jingxueRekrutierungPankreaskarzinom; Lipoprotein a; Gesamtüberleben; PrognoseChina
-
Jiangsu Province Nanjing Brain HospitalRekrutierung
-
Mount Sinai Hospital, CanadaNoch keine RekrutierungHypotonie auf InduktionKanada
-
UCB Biopharma SRLNoch keine RekrutierungEpilepsie in der Kindheit | Juvenile Abwesenheitsepilepsie
-
North Jersey AIDS Alliance dba North Jersey Community...City University of New York, School of Public HealthNoch keine RekrutierungHIV-Infektionen | Überdosis | HCV